The Israeli public health response to wild poliovirus importation

Lancet Infect Dis. 2015 Oct;15(10):1236-1242. doi: 10.1016/S1473-3099(15)00064-X. Epub 2015 Jul 23.

Abstract

In 2013, a silent wild poliovirus type 1 importation and sustained transmission event occurred in southern Israel. With the aim of preventing clinical poliomyelitis and ensuring virus re-elimination, the public health response to the importation event included intensification of clinical and environmental surveillance activities, enhancement of vaccine coverage, and supplemental immunisation with a bivalent oral polio vaccine against wild poliovirus types 1 and 3. A national campaign launched in August, 2013, resulted in vaccination of 943,587 children younger than 10 years (79% of the eligible target population). Expanded environmental surveillance (roughly 80% population coverage) documented a gradual disappearance of wild poliovirus type 1 in the country from September, 2013, to April, 2014. No paralytic poliomyelitis case was detected. A prompt extensive and coordinated national public health response, implemented on the basis of evidence-based decision making, successfully contained this serious importation and sustained transmission event of wild poliovirus to Israel. On April 28, 2015, WHO officially declared Israel as a polio-free country.

MeSH terms

  • Carrier State / diagnosis*
  • Child
  • Child, Preschool
  • Communicable Disease Control / methods*
  • Environmental Microbiology*
  • Epidemiological Monitoring
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Israel / epidemiology
  • Male
  • Poliomyelitis / prevention & control*
  • Poliovirus / isolation & purification*
  • Public Health Administration*
  • Travel